Cite
MLA Citation
Akinbami Adenugba et al.. “Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in HCV-infected Liver Transplant Recipients.” Transplantation, vol. 105, no. 10, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100174360434.0x00001d